Gabon Iodine

Gambia

Vitamin A

 Iron Ghana
     
MN Project Home Page Bookmarks
Country Index Epidemiological Data
Country Profile Policy & Legislation
Program Data
Monitoring
Program Resources

EPIDEMIOLOGICAL DATA
     
Clinical Vitamin A Deficiency
Most Recent Clinical VAD Survey - MICS 2000
Date: November 1999
Groups Surveyed: Children, Pregnant and Lactating Women
Sample Size: 2139:  518 children, 324 pregnant women, 441 lactating women
Sampling Strategy: Randomly selected
Estimated Prevalence of VAD:  

Region/Group*

Children (1-5 years)

Sample Size

Prevalence in Sample %

High Risk Def.       

Banjul

20

60

0

Kanifing Municipal Council (KMC)

94

54

7

Western Division (WD)

55

47

0

Lower River Division (LRD)

22

68

18

Central River Division (CRD)

82

77

10

North Bank Division (NBD)

42

71

5

Upper River Division (URD)

90

69

18

National Total

405

64

9

 
 
Sub-clinical Vitamin A Deficiency  -- Not Reported
 
     
 

POLICY AND LEGISLATION
 

Legislation on VAD

         

No information reported.
 

Government Agency to Address VAD

         

No information reported.
 
     

PROGRAM DATA
   
Supplementation
Program Description
     Available information via MICS 2000:  11.8% of post-partum women are supplemented within 8 weeks, 3.7% of children 6 - 59 months old were supplemented 6 weeks prior to survey.
Targeting

    

Children 6 - 59 mos and post partum women.
Implementation

    

Supplementation is given through national immunization days and health clinics.

    

The sizes of the doses given are 200,000 and 100,000 IU.

    

Infants between age of 6 and 11 months are given a 100,000 IU dose while the others are given a 200,000 IU dose.  This is supposed to be done every 6 months until age 5.

    

All newly delivered mothers (within 8 weeks of delivery) who attend Maternal and Child Health services are to be given a 200,000 IU dose.

    

Supplementation is also provided to measles patients.
 

Fortification
    

There are no VitA fortification programs
     
     
 
MONITORING
 

Clinical and Sub-clinical VAD- Not reported.
Supplementation - Not reported.
Fortification - Not reported.
     
     
PROGRAM RESOURCES
   
Donor Agencies -- Not Reported
 
VAD Program Funding History and Projections  -- Not Reported